Jacksonville Wealth Management LLC acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 4,886 shares of the biotechnology company’s stock, valued at approximately $2,904,000. Axon Enterprise makes up approximately 2.7% of Jacksonville Wealth Management LLC’s investment portfolio, making the stock its 10th biggest holding.
Other large investors also recently modified their holdings of the company. Quent Capital LLC increased its stake in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC boosted its position in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares in the last quarter. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $41,000. Planning Capital Management Corp boosted its position in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares in the last quarter. Finally, Friedenthal Financial bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $51,000. 79.08% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities research analysts have commented on AXON shares. Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities boosted their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $504.92.
Axon Enterprise Stock Down 0.5 %
Axon Enterprise stock opened at $610.32 on Friday. The stock has a market cap of $46.54 billion, a PE ratio of 157.71, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The stock has a fifty day moving average of $617.65 and a 200 day moving average of $470.75.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- What is Forex and How Does it Work?
- Bloom Energy: Powering the Future With Decentralized Energy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.